Legislating Healthcare: Ensuring Patient Access in the Trump Administration Ensuring Patient Access in the Trump Administration During times of legislative changes, patients are often left to wonder how they and their care will be impacted. Advocacy experts must take...
Looking Forward: Will 2018 be Pharma’s Greatest Year Yet? Will 2018 be Pharma’s Greatest Year Yet? The pharmaceutical industry has faced many changes in 2017. Legislative uncertainty, patient-centricity, and ransomware threats are just a few of the industry’s...
How could the AHCA Impact Pharma? Forecasting Legislation and Industry Changes in the Trump Administration Forecasting Legislation and Industry Changes in the Trump Administration With the recent passing of the American Health Care Act (AHCA) through the U.S....
The key to a successful product launch and quality patient care is market access and coverage. Obtaining high formulary coverage is crucial to ensuring patients’ access to treatments and increases the likelihood of continued disease fighting development. The...
British PBM, Harvard Pilgrim, announced this week two outcome based contracts with pharmaceutical leader AstraZeneca. The first contract will monitor the outcomes of Brilinta, a treatment lowering the chance of another heart attack or death from a heart attack in...